IR@PKUHSC  > 北京大学临床肿瘤学院  > 医学影像科
学科主题临床医学
Effect of Recombinant Adenovirus-p53 Combined With Radiotherapy on Long-Term Prognosis of Advanced Nasopharyngeal Carcinoma
Pan, Jian-ji1; Zhang, Shan-wen1; Chen, Chuan-beng1; Xiao, Shao-wen1; Sun, Yan1; Liu, Chang-qin1; Su, Xing1; Li, Dong-ming1; Xu, Gang1; Xu, Bo1; Lu, You-yong1
刊名JOURNAL OF CLINICAL ONCOLOGY
2009-02-10
DOI10.1200/JCO.2008.18.9670
27期:5页:799-804
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
关键词[WOS]WILD-TYPE P53 ; SQUAMOUS-CELL CARCINOMA ; GENE-TRANSFER ; LUNG-CANCER ; IN-VIVO ; THERAPY ; EXPRESSION ; HEAD ; ANGIOGENESIS ; MUTATIONS
英文摘要

Purpose

To centrally assess the safety, efficacy, and 6-year follow-up of recombinant adenovirus-p53 (rAd-p53) combined with radiotherapy (RT) for patients with nasopharyngeal carcinoma (NPC).

Patients and Methods

A randomized controlled clinical study on rAd-p53 combined with RT in 42 patients with NPC was compared with a control group of 40 patients with NPC treated with RT alone. In the group receiving rAd-p53 combined with RT, rAd-p53 was intratumorally injected once a week for 8 weeks. Concurrent RT (70 Gy in 35 fractions) was given to the nasopharyngeal tumor and neck lymph node. Patients and tumors were monitored for adverse events and responses.

Results

rAd-p53-specific p53 mRNA was detected in postinjection of rAd-p53 biopsies from 16 (94.1%) of 17 patients. Upregulation of p21/WAF1 and Bax and downregulation of vascular endothelial growth factor were observed in postinjection tumor biopsy. Complete response rate in the group receiving rAd-p53 combined with RT was observed at 2.73 times that of the group receiving RT alone (66.7% v 24.4%). Six-year follow-up data showed that rAd-p53 significantly increased the 5-year locoregional tumor control rate by 25.3% for patients with NPC treated with irradiation (P = .002). The 5-year overall survival rate and 5-year disease-free survival rate of the group receiving rAd-p53 combined with RT were 7.5% (P = .34) and 11.7% (P = .21) higher than those of the group receiving RT alone. No dose-limiting toxicity or adverse events appeared, except for transient fever after rAd-p53 administration.

Conclusion

In patients with NPC, rAd-p53 was safe and biologically active. Our results indicated that rAd-p53 improves radiotherapeutic tumor control and survival rate in patients with NPC.

语种英语
WOS记录号WOS:000263139800022
资助机构National Science Committee
引用统计
被引频次:72[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/50640
专题北京大学临床肿瘤学院_医学影像科
北京大学临床肿瘤学院_肿瘤放疗科
作者单位1.Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Dept Radiotherapy, Beijing 100036, Peoples R China
2.Fujian Prov Canc Hosp, Fuzhou, Peoples R China
推荐引用方式
GB/T 7714
Pan, Jian-ji,Zhang, Shan-wen,Chen, Chuan-beng,et al. Effect of Recombinant Adenovirus-p53 Combined With Radiotherapy on Long-Term Prognosis of Advanced Nasopharyngeal Carcinoma[J]. JOURNAL OF CLINICAL ONCOLOGY,2009,27(5):799-804.
APA Pan, Jian-ji.,Zhang, Shan-wen.,Chen, Chuan-beng.,Xiao, Shao-wen.,Sun, Yan.,...&Lu, You-yong.(2009).Effect of Recombinant Adenovirus-p53 Combined With Radiotherapy on Long-Term Prognosis of Advanced Nasopharyngeal Carcinoma.JOURNAL OF CLINICAL ONCOLOGY,27(5),799-804.
MLA Pan, Jian-ji,et al."Effect of Recombinant Adenovirus-p53 Combined With Radiotherapy on Long-Term Prognosis of Advanced Nasopharyngeal Carcinoma".JOURNAL OF CLINICAL ONCOLOGY 27.5(2009):799-804.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Pan, Jian-ji]的文章
[Zhang, Shan-wen]的文章
[Chen, Chuan-beng]的文章
百度学术
百度学术中相似的文章
[Pan, Jian-ji]的文章
[Zhang, Shan-wen]的文章
[Chen, Chuan-beng]的文章
必应学术
必应学术中相似的文章
[Pan, Jian-ji]的文章
[Zhang, Shan-wen]的文章
[Chen, Chuan-beng]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。